| 股號 / 名稱 | 營收 | 稅後淨利 |
| NVO 諾和諾德 | 11,795,224,320.0 | 3,147,343,920.0 |
| ABT 美國雅培 | 11,369,000,000.0 | 1,644,000,000.0 |
| MDT 美敦力 | 8,961,000,000.0 | 1,382,000,000.0 |
| SYK 史賽克 | 6,057,000,000.0 | 859,000,000.0 |
| BSX Boston Scientific Corp | 5,065,000,000.0 | 756,000,000.0 |
| PHG Koninklijke Philips NV | 5,048,741,160.0 | 220,633,040.0 |
| ZBH Zimmer Biomet Holdings Inc | 2,001,400,000.0 | 231,200,000.0 |
| RMD 瑞思邁 | 1,335,582,000.0 | 348,536,000.0 |
| QDEL QuidelOrtho Corp | 699,900,000.0 | -733,000,000.0 |
| OMI Owens & Minor Inc | 697,264,000.0 | -5,607,000.0 |
| NVST Envista Holdings Corp | 669,900,000.0 | -30,300,000.0 |
| BIO Bio Rad Laboratories Inc | 653,000,000.0 | -341,900,000.0 |
| BRBR Bellring Brands Inc | 648,200,000.0 | 59,600,000.0 |
| ICUI ICU Medical Inc | 536,990,000.0 | -1,855,000.0 |
| EYE National Vision Holdings Inc | 487,330,000.0 | 3,372,000.0 |
| PAHC Phibro Animal Health Corp | 363,893,000.0 | 26,527,000.0 |
| HCM HUTCHMED (China) Ltd | 277,677,000.0 | 455,555,000.0 |
| WRBY Warby Parker Inc | 221,680,000.0 | 5,874,000.0 |
| NEOG Neogen Corp | 209,189,000.0 | 36,338,000.0 |
| TGTX TG Therapeutics Inc | 161,709,000.0 | 390,895,000.0 |
| ATRC AtriCure Inc | 134,269,000.0 | -267,000.0 |
| INMD Inmode Ltd | 93,165,000.0 | 21,863,000.0 |
| MGNX MacroGenics Inc | 72,839,000.0 | 16,822,000.0 |
| VMD Viemed Healthcare Inc | 71,914,000.0 | 3,600,000.0 |
| EOLS Evolus Inc | 68,967,000.0 | -15,737,000.0 |
| CERS Cerus Corp | 60,237,000.0 | -20,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 41,630,000.0 | -45,057,000.0 |
| ZVIA Zevia PBC | 40,844,000.0 | -2,848,000.0 |
| QTRX Quanterix Corp | 40,233,000.0 | -33,517,000.0 |
| INFU InfuSystem Holdings Inc | 36,488,000.0 | 2,259,000.0 |
| VALN Valneva SE | 34,513,814.22 | -52,054,140.9 |
| BLFS BioLife Solutions Inc | 28,067,000.0 | 621,000.0 |
| XGN Exagen Inc | 17,244,000.0 | -7,087,000.0 |
| RMTI Rockwell Medical Inc | 15,927,000.0 | -1,753,000.0 |
| ZYXI Zynex Inc | 13,360,000.0 | -42,914,000.0 |
| APYX Apyx Medical Corp | 12,877,000.0 | -1,955,000.0 |
| MYO Myomo Inc | 10,090,700.0 | -3,662,920.0 |
| IMCC IM Cannabis Corp | 9,954,021.15 | -2,777,582.25 |
| UTMD Utah Medical Products Inc | 9,812,000.0 | 2,631,000.0 |
| FLGC Flora Growth Corp | 9,748,000.0 | -3,627,000.0 |
| CTSO Cytosorbents Corp | 9,485,000.0 | -3,170,000.0 |
| ICCC ImmuCell Corp | 5,506,120.0 | -139,750.0 |
| NEPH Nephros Inc | 4,764,000.0 | 337,000.0 |
| UG United-Guardian Inc | 2,264,260.0 | 268,440.0 |
| SNES Senestech Inc | 690,000.0 | -1,298,000.0 |
| GCTK GlucoTrack Inc | 0.0 | -4,171,000.0 |
| PHGE Biomx Inc | 0.0 | -9,166,000.0 |
| OMER Omeros Corp | 0.0 | -21,243,000.0 |
| VERU Veru Inc | 0.0 | -7,323,100.0 |
| CLRB Cellectar Biosciences Inc | 0.0 | -4,443,880.0 |
| CAPR Capricor Therapeutics Inc | 0.0 | -24,570,650.0 |
| ORMP Oramed Pharmaceuticals Inc | 0.0 | 48,389,000.0 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股營收排名、龍頭是誰？
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例